chrisvoncsefalvay/vaers-outcomes huggingface dataset:
suspected vaccination failure; received both shots / had 2 severe attacks since injections / Shingles pain is DEEP; pain / Shingles pain is DEEP / nothing they did stopped the pain; shingles pain is deep with topical rash; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, pain and rash. The patient was treated with antiinflammatory/antirheumatic products (Anti Inflammatory Drug (Nos)) and opioids {nos} (Opioid). On an unknown date, the outcome of the vaccination failure and shingles were unknown and the outcome of the pain and rash were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, pain and rash to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided are as follows: The case was reported by patient himself/herself. The age at vaccination was not reported. The patient received both the Shingles shots and they did not work and had 2 severe attacks of shingles since injections. The patient also had shingles pain which was deep with topical rash. The pain was excruciating, and the patient was given anti-inflammatory drugs, which did not help. Even opioid pain drugs had no effects. The patient found no drug or treatment that reduced the pain. The patient went to emergency outpatient clinic both times and nothing they did could stop the pain. This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting.
12:30 MMR and Hepatitis B vaccine given. 13:30 complained of SOB, hives on neck, trunk back, swollen lips, bronchospasm. Rx - epinephrine/solumedrol. Albuterol.
PATIENT RECEIVED REGULAR COVID INSTEAD OF BIVALENT.  NO REACTIONS OR SYMPTOMS NOTED.
Pt recvd vax on 8OCT92 & later that day devel fever which ranged from 101 & 106; pt was taken to ER & dx w/OM;
anaphylaxis; This is a spontaneous report from a contactable Nurse reported for (patient). A 13-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration on 07Jul2021(age at vaccination 13 years) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient was not pregnant at the time of vaccination. The patient visited emergency room for reported events. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced anaphylaxis on 07Jul2021. The outcome of event was unknown.  Information about lot/batch number is requested.; Sender's Comments: There is a reasonable possibility that the event Anaphylactic Reaction was related to the use if suspect product BNT162b2 based on known drug safety profile and the close temporal relationship.
Patient reports that her arm swelled up the size of a baseball and that she ran a fever and was in bed for 2 days.
Mother stated patient started with itching to the right deltoid in the evening of 04/04/11. Later the itching developed into a swollen, red and warm to the touch rash measuring 3 inches by 2 inches. Patient was seen by FNP on 04/06/11 in the AM and diagnosed with Allergic dermatitis due to an allergic reaction to the vaccines. Patient was treated with an injection of Diphenhydramine 12.5 IM left deltoid and a prescription for Hydrocortisone cream to apply daily as needed.
STOMACH ISSUES (ACID REFLUX); DIFFICULTY SLEEPING FROM THE ITCHINESS; LITTLE RED SPOTS ON HER LOWER LEGS, WHICH HAVE NOW TURNED BROWN (IT WORSE ON HER RIGHT LEG); ITCHY SKIN ALL OVER THE BODY THAT AFFECTS DIFFERENT PARTS AT DIFFERENT TIMES; This spontaneous report received from a patient concerned an 85 year old female. The patient's weight was 132 pounds, and height was 63 inches. The patient's concurrent conditions included: acid reflux, non smoker, and drinks alcohol, and other pre-existing medical conditions included: The patient had no known allergies and did not have any drug abuse/illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609 expiry: UNKNOWN) dose was not reported, administered on 19-MAR-2021 for prophylactic vaccination. Concomitant medications included hydroxyzine for acid reflux, and omeprazole for acid reflux. On 05-AUG-2021, the patient experienced itchy skin all over the body that affects different parts at different times. On an unspecified date, the patient experienced stomach issues (acid reflux), difficulty sleeping from the itchiness, and little red spots on her lower legs, which have now turned brown (it worse on her right leg). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from itchy skin all over the body that affects different parts at different times, and difficulty sleeping from the itchiness, and the outcome of stomach issues (acid reflux) and little red spots on her lower legs, which have now turned brown (it worse on her right leg) was not reported. This report was non-serious.
Bone spur on an old finger fracture appeared spontaneously shortly after vaccine. Untreated as of now.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. On 12-DEC-2017, the patient was vaccinated with a first dose of expired VARIVAX lot # L049532, expiry date 08-DEC-2017 for prophylaxis. No adverse event was reported.
Patient had arm pain that was substantial, followed by partial immobility and limited range of motion of the injection arm. States feels like nervous system pain or muscular impairment.
@11:35 pt complain of palpations and throat closing. pt was in distressed. epi pen given @ 11:37. @ 11:44 pt symptoms improving and transported to the hospital by ambulance @ 11: 50.
Rash "morbilliform" on face, chest abd, back and extremities x2 days "No itch, no pain, no change in diet, no fever. Received vaccines 10 days prior expected course.
Administered 'ZOSTAVAX' for the 'Prevention of Shingles' in the 'muscle, just like a regular shot; Non-Hodgkin's Lymphoma; This spontaneous report has been received from an 85-year-old male patient, regarding himself.  The patient's medical history, concurrent conditions, historical drugs, and concomitant therapies were not reported.  On 09-FEB-2022, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (dose, anatomical location, lot number, and expiration date were not provided) administered intramuscularly (reported as " in the muscle, just like a regular shot") for the Prevention of Shingles, by a pharmacist (Incorrect route of product administration). The patient did not experience any reactions following the administration of zoster vaccine live (ZOSTAVAX).   On an unspecified date in 2022, the patient experienced Non-Hodgkin's Lymphoma, for which he received an unknown chemotherapy from unknown manufacturer every 6 weeks. The patient was currently off of the unknown chemotherapy for a couple weeks.   The outcome of the Non-Hodgkin's Lymphoma event and its causal relationship with zoster vaccine live (ZOSTAVAX) were not reported.   At current call time, the patient affirmed and confirmed "how affected product was zoster vaccine live (ZOSTAVAX)", however he was unable to further clarify these statements at current call time. No further information was provided.  Upon internal review, the event Non-Hodgkin's Lymphoma was determined to be medically significant.
Had flu vaccine at approx 9:30am 11/6/06 and developed severe headache at 4pm, which lasted 36 hours. No prior history of headaches.
The day after the shot I went into work and my arm was bothering me I was feeling feverish and COVID symptoms were flaring up big time. I left work early to visit the Pulmonologist appointment I already had. I didn't have a fever at the Pulmonologist appointment but when I got home I had a 101.7 and my fingers were swollen, upper arm was red where the injection was. I took Tylenol Advil and light stretches. That following Monday I went to my primary doctor and she said it was swollen and I had a slight reaction/ she said to take Aleive, Tylenol and ice the arm. Chest area, lymph nodes were swollen. Temperature went down to normal on Wend. When I had my follow-up appointment Thursday it was better. So a week later it was better.
Severe projectile vomiting; Nausea; This is a spontaneous report from a non-contactable consumer, the patient. A 16-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 05Oct2021 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Sep2021 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. On 06Oct2021, the patient experienced severe projectile vomiting and nausea. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of vomiting projectile and nausea and included treatment with prochlorperazine. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events vomiting projectile and nausea was not resolved at the time of report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Fever of 100.7, her normal is around 96 extreme chills - had to use a heating pad Confusion - couldn't figure out what the thermometer was used for Hallucinations - She though she was flying around the bedroom, but had to stay above her dog, who was on the bed to protect it. Can't remember
This is a spontaneous report from a contactable nurse. This nurse reported similar events for two patients. This is second of two reports. A 3-month old female patient received the second single dose of PREVNAR13, Wyeth, lot # H08091 and expiration date: FEB2015) intramuscular in the left thigh at a dose of 0.5 ml and the second dose of ROTATEQ (Merck, batch/lot# J008383; Expiration date: 28NOV2014) orally, both on 23MAY2014 at 11:00 AM, at private doctor's office/hospital, purchased with private funds. Medical history was none; has one sister; birth weight 6 lbs 3 oz. The patient previously received the first dose of hepatitis B vaccine on 15FEB2014, the first dose of PREVNAR 13 on 07APR2014 and the first dose of ROTATEQ on 07APR2014. Relevant concomitant medication included the second dose of hepatitis B vaccine (Sanofi, Batch/Lot # JJ07298; Exp. Date: 15FEB2016) intramuscular in the left thigh and the second dose of DPAT, HiB; IPV (Sanofi, Batch/Lot #C4683AA, Expiration Date 02NOV2016) intramuscular in the right thigh both on 25APR2014, at an unknown dose. On 23MAY2014 the patient was not eating and sleeping more than usual, and on 24MAY2014 had high fever, experienced yeading cranky (irritability) and leg swollen at injection site. Relevant laboratory data were unknown. The patient visited the door on 24MAY2014 because of reported adverse events. Therapeutic measures taken in response to the events, high fever and leg swollen at injection site, and included TYLENOL since an unknown date in MAY2014 at an unknown dose and frequency however the therapeutic measures taken in response to the other reported events were not provided. The patient had recovered from fever, yeading cranky, and leg swollen at injection site on 25MAY2014 and from the events, not eating and sleeping more than usual, on an unknown date in MAY2014, within 24-48 hrs. The reporter was informed regarding the reported adverse events with the use of the product and confirmed them. The reporter considered there was a reasonable possibility that the events were related to PREVNAR13. Follow-up attempts completed. No further information expected. Follow-up (02JUL2014): Follow-up attempts completed. No further information expected. Follow-up (14OCT2014): New information from the same contactable nurse who reported on behalf of physician includes: confirmation of the events and new event added, administration date modified, route of administration, vaccination history, onset date and recovery dates of the events, causality assessment. Follow-up (07NOV2014):; New information received from a contactable nurse includes on behalf of the physician: vaccines trade names; birth weight; hepatitis B vaccine and DPAT, HIB, IPV vaccination sites; vaccination privately done. Follow-up (13NOV2014): New information reported from the contactable office manager reporting on behalf of a physician includes: new healthcare professional reporter information. Follow-up (08JAn2015): Follow-up attempts completed. No further information expected. Follow-up (21JAN2015): New information reported includes confirmation that DPAT, HIB, IPV was considered as a single vaccine according to information provided.
Syncopal event starting 5 minutes after COVID-19 vaccine. Upon awakening, complained of headache, mild chest tightness, nausea.
Sever pain in left arm after 3-4 days of vaccination. Pain subsided and left pointer finger and thumb left with extreme weakness.  Condition diagnosed by a hand specialist to be Parsonage Turner Syndrome. There is no treatment for this.  This has left me with a permanent disability.
Information has been received from a license practical nurse referring to an unspecified number of patients of unknown age and gender. Concurrent conditions and medical history of the patients were not reported. Between the dates of 01-SEP-2015 and 07-OCT-2015, the patients were inadvertently vaccinated with unspecified doses of improperly stored GARDAISL (lot# K010574 with expiration date 08-APR-2017, and K009482 with expiration date 06-MAR-2017, dose and route unspecified). Other suspect and concomitant therapies were not reported. No adverse effects were reported. This is one of two reports received from the same source. Additional information has been requested.
A non-serious, spontaneous report of got a full vial of FLUMIST in each nostril was received from a nurse practitioner regarding a six-year-old female patient following FLUMIST. On 06-Oct-2009, the patient received two full vials of FLUMIST (0.2 ml in each nostril). There was no adverse event associated with this medication error, therefore treatment and reporter/sponsor causality assessments are not applicable and the event is considered resolved.
After first shot, had outbreak of psoriasis after 7 days on chest. Have not had an outbreak in that area in 10 years.  2 Weeks after second shot, had second outbreak of psoriasis on left side of body, also had outbreak of shingles on L arm and L side of Face, around and under the L eye Went to the walk in clinic on SAT 5/22/201 after noticing purple colored blemishes/eczema on face , was diagnosed with shingles and prescribed Prednisone and Acyclovir
7.21.21: patient seen 4 days ago by provider and tested positive for COVID-19; given azithromycin Z-pak, but not helping so came to ED with worsening shortness of breath, left ear pain, and fatigue.  patient previously received J&J COVID-19 vaccine on 4/2/2021.  Diagnosed with COVID-19 pneumonia, acute resp failure, hypoxia.  7/27/21: patient discharged
I woke up at 1AM on the 26th in excruciating pain with a high fever and very disoriented. Assuming it was all from the fever. I took two Advil and tried to go back to sleep. The fever went down some and then went back up. It was 2 days of the fever going up and down. Doctor believes it caused a flare in my RA and I had excruciating pain and a really bad headache. It was all the same symptoms coming and going from Thursday to Saturday. By Saturday evening, I took a nap and it was just all gone. I did call the doctor in the morning at some point because the fever kept going up and down and it was so high. It's not normal for my temperature to go up to 103. He said if anything worsens or if I experienced any palpitations to go to the emergency room, but it never did. As fast as it came on, it went away. Wasn't anything long term.
red circle and bruising on my arm; red circle and bruising on my arm; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "migraines" (unspecified if ongoing); "Drug allergies: NKDA" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: ERYTHEMA (non-serious), CONTUSION (non-serious), outcome "unknown" and all described as "red circle and bruising on my arm".  Additional information: Clinical course: It was reported that patient had a reaction to Pfizer covid shot. She got a red circle and bruising on her arm.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I had nerve pain at the time, but have since suffered a huge increase in my tardive dyskinesia
I had my period two times, two weeks apart; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 27 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 14Apr2021 (Lot number: EW0153) at the age of 27 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing). Concomitant medication(s) included: ADDERALL. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: ER2613, Location of injection: Arm Right, Vaccine Administration Time: 12:00 PM), administration date: 24Mar2021, when the patient was 27 years old, for Covid-19 immunization. The following information was reported: MENSTRUAL DISORDER (non-serious) with onset 23Apr2021 12:00, outcome "recovered" (Nov2021), described as "I had my period two times, two weeks apart". The event "i had my period two times, two weeks apart" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of menstrual disorder. No follow-up attempts are possible. No further information is expected.  Additional information: The patient have always had a very regular and normal period since I was 12. The month of my second Covid shot she had This is extremely unusual for my body so she asked friends (approximately 20 women), and they all said they've had issues with their period since getting vaccinated too. She went to my doctor and she said she's had numerous women come to her with this issue as well. We followed up with blood work and an ultrasound and my period two times, two weeks apart. This continued for 6 months, ending in this past November.  there is no other explanation for this abnormal bleeding other than a possible correlation to the vaccine. Due to this experience, I have not gotten the booster even though I want to. But I fear that the vaccine could make this occur again, and even affect my fertility. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19.
Inflammation in the nape of neck, behind the head/neck after first dose medications prescribed by doctor: Ibuprofen, Prednisone, Baclofen. Back inflammation (tailbone/lumbar) area after second dose.
patient called 5 days after receiving vaccine and reported that about an hour after he got his vaccine, his lower body began to get numb with severe lower body cramping/pain.  His cramping has continued.
Same arm cellulitis, warmth, pain, edema, began approx 8 hours after injection, reaction is more medial and distal than site of injection
Sore arm; fever 102.6/ 101.6; body aches; This is a spontaneous report from a contactable consumer (patient). A 54-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. Patient received first dose of BNT162B2 on an unspecified date. The patient experienced sore arm, fever 102.6/ 101.6, body aches on an unspecified date after 2nd dose of COVID 19 vaccine. The event outcome was unknown.  Information on the lot/batch number has been requested.
4/29 4PM, patient developed red, raised, rash; blotchy appearance and irritability 4/29/03. Spread over trunk, extremities over next 16-20 hours. Small raised areas in red blotches.
This spontaneous report as received from a physician refers to an unspecified number of patients of unknown age and gender. The patients' concurrent conditions and medical history was not reported. On unknown dates, the patients were late receiving third doses of GARDASIL 9 (lot #, expiration date, dose, route and site of administration were not reported). Concomitant medications were not reported. This is one of several reports from the same reporter. Additional information has been requested.
+ RASH, FOLLICULAR, MILDLY PRURITIC, 9 DAYS POST VACCINATION.  NO FEVER.  A/P: MILD ERYTHEMA MULTIFORME PLAN: GAVE ALLEGRA 180MG QD WITH COMPLETE RESOLUTION
Patient reports soreness, right lower quadrant front side, sore to touch which began exactly 2 weeks after receiving SHINGRIX. Patient states his doctor has told him he has Shingles, with no visible rash.
Systemic rash, sweats, chills, myalgia, groin discomfort, headache and fatigue Benadryl recommended.  Gradually improved
Thyroid, skin rash, pruritus ani, insomnia, back pain, depression, diabetes, high blood pressure, joint aches, etc. For more information contact hospital.
fever 103, swollen day 2, vomiting started 4AUG95 100 z; taken to MD 4AUG95; MD gave pt advil for fever;